The Scientist

» FDA and immunology

Most Recent

image: Scott Gottlieb Nominated to Lead the FDA

Scott Gottlieb Nominated to Lead the FDA

By | March 13, 2017

President Donald Trump has nominated physician Scott Gottlieb to be the next FDA commissioner.

0 Comments

image: Tom Price Confirmed as HHS Director

Tom Price Confirmed as HHS Director

By | February 10, 2017

The orthopedic surgeon is confirmed to lead the US Department of Health and Human Services.

2 Comments

A conversation with public health expert Lynn Goldman, a former assistant administrator at the US Environmental Protection Agency

1 Comment

image: Opinion: Improving FDA Evaluations Without Jeopardizing Safety and Efficacy

Opinion: Improving FDA Evaluations Without Jeopardizing Safety and Efficacy

By | February 1, 2017

What can be done to lower development costs and drug prices?

4 Comments

image: Trump’s Crackdown on Federal Regulations

Trump’s Crackdown on Federal Regulations

By | February 1, 2017

The President has signed an executive order requiring that federal agencies, including the FDA, to cut two regulations for every new one they adopt.

2 Comments

image: Unique Antibodies Open Path Toward New HIV Vaccines

Unique Antibodies Open Path Toward New HIV Vaccines

By | January 27, 2017

A family of broadly neutralizing antibodies from a chronically infected donor provides a schematic for designing vaccines and treatments that target multiple strains of the virus.

0 Comments

image: Marijuana Research Still Stymied by Federal Laws

Marijuana Research Still Stymied by Federal Laws

By | January 23, 2017

US scientists continue to have a hard time getting funding to study the health impacts of the drug. But cannabis research in Canada—where medical marijuana is legal nationwide—is different story.

1 Comment

image: Califf Vacates FDA’s Top Post

Califf Vacates FDA’s Top Post

By | January 20, 2017

Robert Califf steps down as FDA Commissioner as Donald Trump takes office.

0 Comments

image: Drug Approval Timeline Same as 20 Years Ago

Drug Approval Timeline Same as 20 Years Ago

By | January 9, 2017

A report finds that new medications still take about 12 years to go from patent to patient.

0 Comments

image: FDA Approves First Treatment for Spinal Muscular Atrophy

FDA Approves First Treatment for Spinal Muscular Atrophy

By | December 28, 2016

The oligonucleotide therapeutic will soon be available in the U.S.

0 Comments

Popular Now

  1. Unstructured Proteins Help Tardigrades Survive Desiccation
  2. What Budget Cuts Might Mean for US Science
    News Analysis What Budget Cuts Might Mean for US Science

    A look at the historical effects of downsized research funding suggests that the Trump administration’s proposed budget could hit early-career scientists the hardest.  

  3. Inflammation Drives Gut Bacteria Evolution
  4. Women Lose Vision After Stem Cell Treatment
Business Birmingham